Carboplatin Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Carboplatin Injection (injection) from Ingenus Pharmaceuticals LLC with status To Be Discontinued. The shortage was first posted on Feb 20, 2026.
Shortage details
- Status
- To Be Discontinued
- Company
- Ingenus Pharmaceuticals LLC
- Package NDC
- 50742-447-45
- Dosage Form
- Injection
- Presentation
- Carboplatin, Injection, 450 mg/45 mL (NDC 50742-447-45)
- Initial Posting
- Feb 20, 2026